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Summary 
 
Irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal disorders with a very strong psychosomatic 
component in the etiology. The prevalence is higher in women and many IBS patients say that food triggers their symptoms. The aim of 
this study was to determine the prevalence of IBS symptoms (GSRS-IBS questionnaire) and the role of diet and dietary habits on IBS 
symptoms in adults. An observational online study with the study-specific questionnaire was completed by 109 adults (84.4% women, 
15.6% men), average age 26 years (21-63 years). 12.8% of study participants had high IBS score (44-75 points). Participants with high 
IBS score tend to overeat (93.0% sometimes, 7.0% always) and skip meals (36.0%) which was proven to worsen IBS symptoms. Coffee 
consumption also worsens IBS symptoms, as well as the consumption of all drinks (without water) and sweets. IBS score was higher in 
participants who said that some food provokes symptoms. Beans (lentil, pea, bean) were proven to increase the risk for high IBS score, 
while strong spices (soup cube, chilli, curry) increase the risk of high IBS only in women (univariate logistic regression). 
 




Irritable bowel syndrome (IBS) is a functional 
gastrointestinal disorder characterized with the recurrent 
abdominal pain followed by altered bowel movements 
(Bilić et al., 2015). IBS poses a significant healthcare 
burden (through direct or indirect expenses) because it 
is one of the most common reasons for sick leave and 
directly decreases person’s quality of life (Lovell and 
Ford, 2012; Halland and Saito, 2015). 
The pathophysiology of IBS is characterized by 
complete absence of histological, endoscopic or 
radiological manifestations of the digestive tract 
disorder (Ikechi et al., 2017). Mechanisms involved in 
the development of IBS are very complex, and 
intertwines biological and psychological factors (Saha, 
2014; El-Salhy, 2015). Due to the fact that functional 
gastrointestinal disorders are classified only according 
to the symptoms manifested, Rome IV classification 
system was developed to enable clinical diagnosis of 
IBS (Drossman and Hasler, 2016). Rome IV criteria 
expands the concept of IBS by underlying alterations in 
the interaction between the enteric nervous system (gut 
and digestion in general) and brain. This interaction is 
related to disturbances in the gut motility, visceral 
hypersensitivity, leaky gut syndrome, and consequently 
has negative impact on the immune response, leads to 
dysbiosis, and alters processing of stimuli in the central 
nervous system (Schmulson and Drossman, 2017). 
Mentioned changes, along with visceral hyperalgesia 
(increased pain sensitivity) and post-infective state 
represented individually and variably are some of the 
possible etiological factors involved in IBS (El-Salhy, 
2012; El-Salhy, 2015; Sikander et al., 2009). 
Many IBS patients claim that their diet is linked to the 
symptoms they are experiencing, and that certain food 
worsens their symptoms (Krogsgaard et al., 2017). 
Today’s standard for IBS diet therapy is the so called 
FODMAP diet characterized by elimination of foods 
rich in fermentable oligo-, di- and monosaccharides and 
polyols (Banjari et al., 2017). This diet seems efficient 
in improving the symptoms in IBS patients (fewer 
symptoms) (Sheperd et al., 2008). 
IBS prevalence is higher among women, regardless of 
age and ethnic group, but almost half of those reporting 
IBS symptoms are up to 35 years old (Canavan et al., 
2014). Various psychological disorders accompany  
70 to 90 % of IBS patients (depression, anxiety and 
others), and they are positively correlated with worse 
IBS symptoms. Still, their interrelation in the 
pathophysiology of IBS is unclear (Longstreth et al., 
2006; Bilić et al., 2015). Learned behaviour from 
parents is among possible etiological factors, while 
having a mother with IBS represents an independent 
risk factor for IBS (Levy et al., 2001). 
Global prevalence of IBS is 11.2% (Lovell and Ford, 
2012), and 11.5% for Europe (Hungin et al., 2003). 
Epidemiological studies conducted in continental part 
of Croatia showed that the prevalence of IBS was high; 
28.00%  for the area of Zagreb, 26.52% for Bjelovar-
Bilogora County and 29.16% for Osijek-Baranja 
County (Grubić et al., 2014). 
 
Subjects and methods 
 
The aim of this study was to determine the prevalence 
of high IBS score in adult population, and analyse the 
role of dietary habits on IBS score. 




An observational online study was carried out on general 
population from the area of Republic of Croatia. The 
research was conducted as a one-time anonymous study. 
Target group were women aged 20 to 40 years, but no 
restriction on gender was set. The questionnaire was 
created specifically for the purposes of this study by 
using a publicly-available program (Google Forms). All 
answers were automatically stored in tabular form (MS 
Office Excel). Social networks were used for the 
recruitment of potential participants. The questionnaire 
was completed by 109 adults, out of which only three 




The questionnaire included general and socioeconomic 
characteristics, body mass and height, and questions 
regarding other medical conditions, regular use of 
medications, use of supplements. Participants were asked 
to assess their physical activity level, smoking habits, and 
their dietary habits (e.g. breakfast skipping, overeating, 
number of meals, etc.). Also, consumption of beverages 
(coffee, tea, alcohol, juices) and spicy foods, and use of 
spices (e.g. “Vegeta”, salt, pepper, chilli) were assessed. 
Gastrointestinal symptom rating scale for IBS (GSRS-
IBS) was integrated in the questionnaire (Wiklund et al., 
2017). On a 7 grade Likert scale participants had to 
assess their subjective experience of gastrointestinal 
symptoms they had felt for past 7 days prior completing 
the questionnaire. Participants’ answers were scored 
and represent IBS score. Minimum score is 13 and 
maximum 91 points. Higher score indicates more IBS 
symptoms present in a person. 
Finally, participants were asked to assess consumption 
of foods listed in the literature as possible propagators 
of the IBS symptoms. Monthly consumption of these 
foods, in a form of a semi-quantitative food frequency 
questionnaire (sFFQ) was assessed (2 or more times a 
day, once a day, 3 to 5 times a week, 1 to 2 times a 
week, 1 to 2 times in two weeks, 1 to 2 times in a month 




Statistical analysis was performed with Statistica (version 
13.4, StatSoft Inc., SAD), at significance level 0.05 and 
0.01. Graph plotting was performed with MS Office 
Excel tool (version 2013, Microsoft Corp., SAD). 
Normality of data distribution was tested by the non-
parametric Kolmogorov-Smirnov test for the comparison 
of medians and arithmetic mean, and histograms plotting. 
Spearman’s correlation test and Mann-Whitney U test for 
the comparison of variables depending on the IBS score 
were used. Univariate logistic regression was performed 
and variables that were shown as significant were tested 
with multivariate logistic regression. 
 
Results and discussion 
 
Total of 109 participants, 92 women (84.4%) and 17 men 
(15.6%), average age 26 years (24 – 35, minimum 21 and 
maximum 63 years) completed the questionnaire. 
Based on the GSRS-IBS scores, participants were 
divided into two groups. The first group achieved low 
IBS score (scores of 13 to 44) while the second group 
had high IBS score (from 44 to 75). The majority of 
study participants had low IBS score (87.1%), with 
almost equally represented men and women in both 
categories. However, more women than men had high 
IBS score (14.1% of women in comparison to 11.8% of 
men) (Fig. 1). The prevalence of high IBS score in 
study population is in line with previously mentioned 




Fig. 1. Gender-based distribution of study participants according to their IBS score (N=109) 
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Median Body Mass Index (BMI) of study participants 
(BMI) was 22.1 (20.2 – 24.9) kg/m2 with no statistical 
difference or correlation between BMI and the category 
of IBS score. The relationship between BMI and IBS is 
still unclear. Presence of gastrointestinal symptoms 
could lead to lower food intake consequently leading to 
malnutrition, therefore IBS patients would have lower 
BMI (El-Salhy, 2015). This was confirmed in a study 
by Kubo et al. (2011). However, Simrén et al. (2001) 
found that patients with IBS are mainly normal 
weighted or overweight. Results of a comprehensive 
review by Pickett-Blakely (2014) showed that obesity 
worsens IBS symptoms. 
Among participants in the low IBS score, 27.4% said 
they have at least one more medical condition and 
28.4% are regularly taking medications. In the high 
IBS score category, 35.7% said they have at least one 
more medical condition and 42.8% of them are 
regularly taking medications. A weak correlation was 
found between IBS score and presence of another 
medical condition (r=0.192) as well as for the use of 
medications (r=0.241). Studies have shown that a 
broad range of medical conditions accompany IBS, 
from gastroesophageal reflux, genitourinary 
symptoms, fibromyalgia, headache, back pain and 
other. Still, IBS is often misdiagnosed or not 
recognized timely and the question is whether other 
conditions are consequences or causes of IBS (Saha, 
2014). Importantly, between 20 and 30% of IBS 
patients are prone to self-medication, mainly to 
antacids, which are ineffective for the symptoms 




Fig. 2. Frequency of meal skipping, overeating and food deprivation in study participants  
according to their IBS score (N=109) 
 
 
Participants do not differ in the average number of 
meals per day according to the IBS score category. 
However, 93.0% of participants with high IBS score 
sometimes overeat, even 71.0% tend to deprive of 
food, and 36.0% said they often skip meals (Fig. 2). 
Studies have shown that IBS patients tend to skip 
meals which can cause disturbances in 
gastrointestinal motility and contribute to the 
symptoms of IBS. It has also been confirmed that the 
relative risk for IBS is 2-4 times greater in persons 
who tend to overeat because large amounts of food in 
one meal can provoke symptoms of IBS (Cozma-
Petruţ et al., 2017). The results of this research 
confirm these statements; week negative correlation 
between food deprivation and higher IBS score was 
found (Table 1). In other words, meal skipping is 
related to higher IBS score, i.e. indicates more 
symptoms of IBS present. 
Higher consumption of all types of drinks (except 
water) shows strong positive correlation with IBS 
score. Also, participants who indicated that some 
food provokes gastrointestinal symptoms (is not 
well tolerated) have higher IBS scores (Table 1). 
Additionally, week correlation was found between 
the consumption of sweets (ice cream, chocolate, 
fruit yoghurt, milk deserts and creamy cakes) and 
higher IBS score (Table 1). This particular result 
can indicate the need for compensation for altered 
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function of serotonin, which has been found in IBS 
patients, and serotonin has a major role in 
gastrointestinal motility (Saha, 2014;  
Sikander et al., 2009). 
 
Table 1. Correlations between some diet characteristics and IBS score of study participants 
 
Diet characteristics  IBS score 
Food deprivation -0.193* 
Coffee 0.284** 
Beverages (except water) 0.328** 
Sweets 0.199* 
Some food is not well tolerated 0.300** 
Spearman’s correlation test, **correlation is significant at p<0.01 
*correlation is significant at p<0.05 
 
Univariate logistic regression showed that the 
consumption of beans (lentil, pea, bean) is the only 
positive predictor for high IBS score (OR = 1,880, 
95% CI = 1,009 – 3,503; P=0,047). Interestingly, the 
use of strong spices represent positive predictor for 
high IBS score only in women (OR = 2,748, 95%  
CI = 1,015 – 7,443; P = 0,047). 
These results on specific foods and IBS symptoms are 
in line with literature findings. Beans have high content 
of galactans that can induce gas production and 
consequently increase intraintestinal pressure, spices 
contain flavour enhancers which can also provoke 
gastrointestinal symptoms, and sweets can cause 
symptoms because of the high sugar content or lactose 
contained in milk-based products (El-Salhy, 2015; El-




The prevalence of high IBS score determined is in 
accordance with previous findings. A number of diet 
characteristics have been identified as positive 
predictors of high IBS score. However, the results on 
the impact of specific foods are still unclear and more 
research on larger populations should be conducted to 
elucidate their role in IBS. Presented results favour 
the complexity of IBS pathophysiology and present 
valuable contribution to the field of IBS. Some of the 
findings could be used in practice for the education of 
IBS patients, especially regarding the foods that 
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